ERBB2 and neoplasm: used IMC to correlate the expression of HER2 protein at plasma membrane of tumor cell, the quantification of CD8+ T cells and their spatial interactions with HER2+ tumor cells, and the response to anti-HER2 trastuzumab therapy.